143 related articles for article (PubMed ID: 10643075)
1. Tumor blood-flow changes following protoporphyrin IX-based photodynamic therapy in mice and humans.
Herman MA; Fromm D; Kessel D
J Photochem Photobiol B; 1999; 52(1-3):99-104. PubMed ID: 10643075
[TBL] [Abstract][Full Text] [Related]
2. Photodynamic therapy for gastrointestinal tumors using three photosensitizers--ALA induced PPIX, Photofrin and MTHPC. A pilot study.
Mĺkvy P; Messmann H; Regula J; Conio M; Pauer M; Millson CE; MacRobert AJ; Bown SG
Neoplasma; 1998; 45(3):157-61. PubMed ID: 9717528
[TBL] [Abstract][Full Text] [Related]
3. Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts.
Peng Q; Warloe T; Moan J; Godal A; Apricena F; Giercksky KE; Nesland JM
Cancer Res; 2001 Aug; 61(15):5824-32. PubMed ID: 11479222
[TBL] [Abstract][Full Text] [Related]
4. A comparative study of tissue distribution and photodynamic therapy selectivity of chlorin e6, Photofrin II and ALA-induced protoporphyrin IX in a colon carcinoma model.
Orenstein A; Kostenich G; Roitman L; Shechtman Y; Kopolovic Y; Ehrenberg B; Malik Z
Br J Cancer; 1996 Apr; 73(8):937-44. PubMed ID: 8611429
[TBL] [Abstract][Full Text] [Related]
5. Photofrin-mediated photodynamic therapy induces vascular occlusion and apoptosis in a human sarcoma xenograft model.
Engbrecht BW; Menon C; Kachur AV; Hahn SM; Fraker DL
Cancer Res; 1999 Sep; 59(17):4334-42. PubMed ID: 10485481
[TBL] [Abstract][Full Text] [Related]
6. Biodistribution of Photofrin II and 5-aminolevulinic acid-induced protoporphyrin IX in normal rat bladder and bladder tumor models: implications for photodynamic therapy.
Xiao Z; Miller GG; McCallum TJ; Brown KM; Lown JW; Tulip J; Moore RB
Photochem Photobiol; 1998 May; 67(5):573-83. PubMed ID: 9613241
[TBL] [Abstract][Full Text] [Related]
7. Photodynamic therapy for polyps in familial adenomatous polyposis--a pilot study.
Mlkvy P; Messmann H; Debinski H; Regula J; Conio M; MacRobert A; Spigelman A; Phillips R; Bown SG
Eur J Cancer; 1995; 31A(7-8):1160-5. PubMed ID: 7577013
[TBL] [Abstract][Full Text] [Related]
8. Aminolevulinic acid-photodynamic therapy combined with topically applied vascular disrupting agent vadimezan leads to enhanced antitumor responses.
Marrero A; Becker T; Sunar U; Morgan J; Bellnier D
Photochem Photobiol; 2011; 87(4):910-9. PubMed ID: 21575001
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of delta-aminolevulinic acid-induced protoporphyrin as a photosensitizer for photodynamic therapy in vivo.
Hua Z; Gibson SL; Foster TH; Hilf R
Cancer Res; 1995 Apr; 55(8):1723-31. PubMed ID: 7712481
[TBL] [Abstract][Full Text] [Related]
10. 5-Aminolevulinic acid photodynamic therapy of transplantable colon adenocarcinoma in BALB/c mice.
Ziółkowski P; Symonowicz K; Osiecka BJ; Rabczyński J
Arch Immunol Ther Exp (Warsz); 1998; 46(5):301-4. PubMed ID: 9832069
[TBL] [Abstract][Full Text] [Related]
11. Evidence for different mechanisms of EMT-6 tumor necrosis by photodynamic therapy with disulfonated aluminum phthalocyanine or photofrin: tumor cell survival and blood flow.
Chan WS; Brasseur N; La Madeleine C; van Lier JE
Anticancer Res; 1996; 16(4A):1887-92. PubMed ID: 8712717
[TBL] [Abstract][Full Text] [Related]
12. Photodynamic therapy of intracranial tissues: a preclinical comparative study of four different photosensitizers.
Lilge L; Wilson BC
J Clin Laser Med Surg; 1998 Apr; 16(2):81-91. PubMed ID: 9663099
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of 5-aminolevulinic acid-mediated photodynamic therapy using light-emitting diodes in human colon cancer cells.
Hatakeyama T; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Ikoma H; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Ochiai T; Kokuba Y; Inoue K; Nakajima M; Otsuji E
Oncol Rep; 2013 Mar; 29(3):911-6. PubMed ID: 23291627
[TBL] [Abstract][Full Text] [Related]
14. Photodynamic therapy of human Barrett's cancer using 5-aminolaevulinic acid-induced protoporphyrin IX: an in-vivo dosimetry study in athymic nude mice.
Pech O; Nagy CD; Gossner L; May A; Ell C
Eur J Gastroenterol Hepatol; 2002 Jun; 14(6):657-62. PubMed ID: 12072600
[TBL] [Abstract][Full Text] [Related]
15. Photosensitization of murine tumor, vasculature and skin by 5-aminolevulinic acid-induced porphyrin.
Henderson BW; Vaughan L; Bellnier DA; van Leengoed H; Johnson PG; Oseroff AR
Photochem Photobiol; 1995 Oct; 62(4):780-9. PubMed ID: 7480155
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcomes of the randomized controlled trial comparing 5-aminolaevulinic acid and Photofrin photodynamic therapy for Barrett's oesophagus related neoplasia.
Kohoutova D; Haidry R; Banks M; Butt MA; Dunn J; Thorpe S; Lovat L
Scand J Gastroenterol; 2018 May; 53(5):527-532. PubMed ID: 29161901
[TBL] [Abstract][Full Text] [Related]
17. In vivo pharmacokinetics of 8-aminolevulinic acid-induced protoporphyrin IX during pre- and post-photodynamic therapy in 7,12-dimethylbenz(a)nthracene-treated skin carcinogenesis in Swiss mice: a comparison by three-compartment model.
Diagaradjane P; Madhuri S; Aruna P; Gupta PK; Ganesan S
Photochem Photobiol; 2002 Jul; 76(1):81-90. PubMed ID: 12126311
[TBL] [Abstract][Full Text] [Related]
18. Interstitial photodynamic therapy in subcutaneously implanted urologic tumors in rats after intravenous administration of 5-aminolevulinic acid.
Xiao Z; Tamimi Y; Brown K; Tulip J; Moore R
Urol Oncol; 2002; 7(3):125-32. PubMed ID: 12474546
[TBL] [Abstract][Full Text] [Related]
19. Oral versus intravenous administration of 5-aminolaevulinic acid for photodynamic therapy.
Loh CS; MacRobert AJ; Bedwell J; Regula J; Krasner N; Bown SG
Br J Cancer; 1993 Jul; 68(1):41-51. PubMed ID: 8318419
[TBL] [Abstract][Full Text] [Related]
20. Effects of photodynamic therapy on adhesion molecules and metastasis.
Rousset N; Vonarx V; Eléouet S; Carré J; Kerninon E; Lajat Y; Patrice T
J Photochem Photobiol B; 1999; 52(1-3):65-73. PubMed ID: 10643074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
